Malignant Prostate Neoplasm — Trials

Malignant Prostate Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

5,981 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,377
Recruiting: 745
Ph III recruiting: 79
Growth YoY: +22.3%
Industry share: 19%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 27%
Trials / 1,000 deaths: 40.6 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (730)

clinicaltrialsPublishedShowing 351–400 of 978 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04886986	Phase I Study of 225Ac-J591 Plus 177Lu-PSMA Small Molecule for Progressive Metastatic Castration Resistant Prostate Cancer	recruiting	Phase 1	42	Weill Medical College of Cornell UniversityOTHER	1	Jun 11, 2026	clinicaltrials
NCT05283330	Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors	recruiting	Phase 1	48	Orano Med Theranostics, SASINDUSTRY	1	Jun 11, 2026